These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23817379)

  • 1. The BpeEF-OprC efflux pump is responsible for widespread trimethoprim resistance in clinical and environmental Burkholderia pseudomallei isolates.
    Podnecky NL; Wuthiekanun V; Peacock SJ; Schweizer HP
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4381-6. PubMed ID: 23817379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of Resistance to Folate Pathway Inhibitors in
    Podnecky NL; Rhodes KA; Mima T; Drew HR; Chirakul S; Wuthiekanun V; Schupp JM; Sarovich DS; Currie BJ; Keim P; Schweizer HP
    mBio; 2017 Sep; 8(5):. PubMed ID: 28874476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei from Thailand.
    Saiprom N; Amornchai P; Wuthiekanun V; Day NP; Limmathurotsakul D; Peacock SJ; Chantratita N
    Int J Antimicrob Agents; 2015 May; 45(5):557-9. PubMed ID: 25758020
    [No Abstract]   [Full Text] [Related]  

  • 4. Method for regulated expression of single-copy efflux pump genes in a surrogate Pseudomonas aeruginosa strain: identification of the BpeEF-OprC chloramphenicol and trimethoprim efflux pump of Burkholderia pseudomallei 1026b.
    Kumar A; Chua KL; Schweizer HP
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3460-3. PubMed ID: 17005832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei.
    Dance DA; Davong V; Soeng S; Phetsouvanh R; Newton PN; Turner P
    Int J Antimicrob Agents; 2014 Oct; 44(4):368-9. PubMed ID: 25245211
    [No Abstract]   [Full Text] [Related]  

  • 6. Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia.
    Crowe A; McMahon N; Currie BJ; Baird RW
    Int J Antimicrob Agents; 2014 Aug; 44(2):160-2. PubMed ID: 24924662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic Resistance Markers in Burkholderia pseudomallei Strain Bp1651 Identified by Genome Sequence Analysis.
    Bugrysheva JV; Sue D; Gee JE; Elrod MG; Hoffmaster AR; Randall LB; Chirakul S; Tuanyok A; Schweizer HP; Weigel LM
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396541
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms of antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis.
    Schweizer HP
    Future Microbiol; 2012 Dec; 7(12):1389-99. PubMed ID: 23231488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular determinants of Burkholderia pseudomallei BpeEF-OprC efflux pump expression.
    Rhodes KA; Somprasong N; Podnecky NL; Mima T; Chirakul S; Schweizer HP
    Microbiology (Reading); 2018 Sep; 164(9):1156-1167. PubMed ID: 30024368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic resistance in Burkholderia species.
    Rhodes KA; Schweizer HP
    Drug Resist Updat; 2016 Sep; 28():82-90. PubMed ID: 27620956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a triplex quantitative real-time PCR assay to detect efflux pump-mediated antibiotic resistance in Burkholderia pseudomallei.
    Webb JR; Price EP; Somprasong N; Schweizer HP; Baird RW; Currie BJ; Sarovich DS
    Future Microbiol; 2018 Sep; 13(12):1403-1418. PubMed ID: 30256166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis.
    Jenney AW; Lum G; Fisher DA; Currie BJ
    Int J Antimicrob Agents; 2001 Feb; 17(2):109-13. PubMed ID: 11165114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the dihydrofolate reductase gene of trimethoprim-resistant isolates of Streptococcus pneumoniae.
    Adrian PV; Klugman KP
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2406-13. PubMed ID: 9371341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility and genetic characterisation of Burkholderia pseudomallei isolated from Malaysian patients.
    Khosravi Y; Vellasamy KM; Mariappan V; Ng SL; Vadivelu J
    ScientificWorldJournal; 2014; 2014():132971. PubMed ID: 25379514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility of Burkholderia pseudomallei isolates in Northern Vietnam.
    Nhung PH; Van VH; Anh NQ; Phuong DM
    J Glob Antimicrob Resist; 2019 Sep; 18():34-36. PubMed ID: 30685463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic and RT-qPCR analysis of trimethoprim-sulfamethoxazole and meropenem resistance in Burkholderia pseudomallei clinical isolates.
    Schnetterle M; Gorgé O; Nolent F; Boughammoura A; Sarilar V; Vigier C; Guillier S; Koch L; Degand N; Ramisse V; Tichadou X; Girleanu M; Favier AL; Valade E; Biot F; Neulat-Ripoll F
    PLoS Negl Trop Dis; 2021 Feb; 15(2):e0008913. PubMed ID: 33592059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of antibiotic susceptibility testing methods for cotrimoxazole with Burkholderia pseudomallei.
    Piliouras P; Ulett GC; Ashhurst-Smith C; Hirst RG; Norton RE
    Int J Antimicrob Agents; 2002 May; 19(5):427-9. PubMed ID: 12007851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year surveillance for Burkholderia pseudomallei in Thailand from 2000 to 2004: prevalence and antimicrobial susceptibility.
    Paveenkittiporn W; Apisarnthanarak A; Dejsirilert S; Trakulsomboon S; Thongmali O; Sawanpanyalert P; Aswapokee N
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S46-52. PubMed ID: 21298845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raising the Stakes: Loss of Efflux Pump Regulation Decreases Meropenem Susceptibility in Burkholderia pseudomallei.
    Sarovich DS; Webb JR; Pitman MC; Viberg LT; Mayo M; Baird RW; Robson JM; Currie BJ; Price EP
    Clin Infect Dis; 2018 Jul; 67(2):243-250. PubMed ID: 29394337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosing regimens of cotrimoxazole (trimethoprim-sulfamethoxazole) for melioidosis.
    Cheng AC; McBryde ES; Wuthiekanun V; Chierakul W; Amornchai P; Day NP; White NJ; Peacock SJ
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4193-9. PubMed ID: 19620336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.